Sitagliptin

Sitagliptin is a DPP‑4 inhibitor with modest HbA1c reduction and cardiovascular neutrality; it has no demonstrated heart failure outcome benefit. DPP-4 inhibitors may in fact exacerbate heart failure symptoms through oedema worsening. This is not the best drug for Mr. Green.

Please go back and re-consider. 

  • Diffusion [undo]
  • Option 2: Only B is correct [undo]
  • Starts seeing a therapist [undo]
  • Areas B, C and D are contaminated and have a high bacterial load. [undo]
  • Not professional [undo]
  • EEG [undo]
  • Areas B and D are contaminated and have a high bacterial load. [undo]
  • Pine tree cones [undo]
  • B, C, E [undo]
  • Does it last? [undo]
  • Trăsături [undo]
  • Quantification of bacterial load: Inoculating the bacterial samples on agar plates [undo]
  • Quantification of bacterial load: Serial dilutions [undo]
  • Sitagliptin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21125
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway